Outset Medical, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
John L. Brottem, General Counsel of Outset Medical, Inc., reported the acquisition of 59,830 restricted stock units.
NASDAQ
Form 4: Outset Medical CFO Acquires RSUs
Renee Gaeta, Chief Financial Officer of Outset Medical, Inc., acquired 71,630 restricted stock units on June 26, 2026, as part of her compensation.
NASDAQ
Outset Medical's Chair and CEO, Leslie Trigg, reported a significant grant of restricted stock units.
NASDAQ
Director Patrick T. Hackett acquired 10,667 restricted stock units in Outset Medical, Inc. as part of a standard equity grant.
NASDAQ
Director Kevin O'Boyle was granted 10,667 restricted stock units (RSUs) by Outset Medical, Inc. on June 4, 2026.
NASDAQ
Outset Medical director Karen Prange was granted 10,667 restricted stock units as part of standard equity compensation.
NASDAQ
Director Brent D. Lang was granted 10,667 restricted stock units (RSUs) by Outset Medical, Inc. on June 4, 2026.
NASDAQ
Director D. Keith Grossman acquired 10,667 restricted stock units in Outset Medical, Inc. as part of an equity grant.
NASDAQ
Outset Medical director Karen Drexler was granted 10,667 restricted stock units as part of standard equity compensation.
NASDAQ
CFO Renee Gaeta sold 17,672 shares of Outset Medical common stock to satisfy tax withholding obligations related to RSU vesting.
NASDAQ
Outset Medical CEO Leslie Trigg sold 3,445 shares of common stock to satisfy tax withholding obligations related to RSU vesting.
NASDAQ
EVP of Operations, R&D & Service Marc Nash sold 1,582 shares of Outset Medical to cover tax obligations related to RSU vesting.
NASDAQ
General Counsel John L. Brottem sold 2,638 shares of Outset Medical common stock to satisfy tax withholding obligations.
NASDAQ
Director Leonard Braden Michael acquired 323,000 shares of common stock in Outset Medical, Inc. for $5 per share, increasing his indirect beneficial ownership.
NASDAQ
Form 4: Insider Buys at Outset Medical
Director Leonard Braden Michael acquired shares of Outset Medical, Inc. through BML Investment Partners, L.P., indicating continued insider confidence.
NASDAQ
Outset Medical, Inc. reports that EVP, Commercial Derick A. Elliott was granted 96,000 restricted stock units on April 6, 2026.
NASDAQ
Outset Medical's General Counsel, John L. Brottem, sold 2,842 shares of common stock to cover tax withholding obligations related to RSU vesting.
NASDAQ
Outset Medical's Chair and CEO, Leslie Trigg, sold 3,361 shares of common stock to cover tax withholding obligations related to RSU vesting.
NASDAQ
Outset Medical's EVP of Operations, R&D & Service, Marc Nash, sold 1,817 shares of common stock to cover tax withholding obligations related to RSU vesting.
NASDAQ
Outset Medical's EVP of Operations R&D & Service, Marc Nash, sold shares to cover tax withholding obligations related to RSU vesting.
NASDAQ
Outset Medical's General Counsel, John L. Brottem, sold 10,494 shares of common stock in non-discretionary 'sell to cover' transactions to satisfy tax withholding obligations.
NASDAQ
Outset Medical CEO Leslie Trigg sold 13,914 shares of common stock to cover tax withholding obligations related to RSU vesting.
NASDAQ
Outset Medical Director Karen Prange was granted 18,667 Restricted Stock Units, vesting quarterly over three years.
NASDAQ
Outset Medical's EVP of Operations R&D & Service, Marc Nash, sold 108 shares of common stock to cover tax withholding obligations related to vested performance share units.
NASDAQ
Outset Medical's General Counsel, John L. Brottem, sold 224 shares of common stock to cover tax withholding obligations related to vested performance share units.
NASDAQ
Outset Medical's Chair and CEO, Leslie Trigg, sold 1,795 shares of common stock to cover tax withholding obligations related to vested performance stock units.
NASDAQ
Outset Medical director Karen Drexler reported the sale of 1,548 shares of common stock at $4.37 per share under a pre-arranged 10b5-1 plan.
NASDAQ
Outset Medical CEO Leslie Trigg sold 916 shares at $4.60 in a non‑discretionary sell-to-cover tied to RSU vesting, maintaining substantial direct and trust holdings.
NASDAQ
On Nov. 17, 2025, EVP Marc Nash sold 247 OM shares at $4.60 in a sell-to-cover tied to RSU vesting, retaining 48,268 shares.
NASDAQ
Outset Medical’s General Counsel sold 388 shares at $4.60 in a non-discretionary, sell-to-cover transaction tied to RSU vesting and now holds 46,495 shares.